Supporting this notion, Lasocki et al. recently showed in a radiogenomic study that MRI features had a stronger prognostic association with survival than CDKN2A/B deletion status in grade 2–3 IDH-mutant astrocytomas [28]. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).